Viewing Study NCT05102292


Ignite Creation Date: 2025-12-24 @ 3:25 PM
Ignite Modification Date: 2026-02-03 @ 12:07 PM
Study NCT ID: NCT05102292
Status: UNKNOWN
Last Update Posted: 2023-08-21
First Post: 2021-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation
Sponsor: Shanghai Henlius Biotech
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anaplastic Thyroid Cancer View
None ATC View
Keywords: